FDA Import Refusal SCS-5472637-8/11/1 — Glaxosmithkline
The FDA refused shipment SCS-5472637-8/11/1 from Glaxosmithkline (Italy) on Jul 3, 2019. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Jul 3, 2019
- Country
- Italy
- Product Category
- Drugs and Biologics
- Product Code
- 66VAY99 MISCELLANEOUS PATENT MEDICINES, ETC.
- Charges
- 75